Source:http://linkedlifedata.com/resource/pubmed/id/19006648
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2009-1-28
|
pubmed:abstractText |
Several studies have shown that miR-34a represses the expression of many genes and induces G1 arrest, apoptosis, and senescence. In the present study, we identified the role of miR-34a in the regulation of tumor cell scattering, migration, and invasion. Down-regulation of miR-34a expression was highly significant in 19 of 25 (76%) human hepatocellular carcinoma (HCC) tissues compared with adjacent normal tissues and associated with the metastasis and invasion of tumors. Furthermore, resected normal/tumor tissues of 25 HCC patients demonstrated an inverse correlation between miR-34a and c-Met-protein. In HepG2 cells, ectopic expression of miR-34a potently inhibited tumor cell migration and invasion in a c-Met-dependent manner. miR-34a directly targeted c-Met and reduced both mRNA and protein levels of c-Met; thus, decreased c-Met-induced phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2). Taken together, these results provide evidence to show the suppression role of miR-34a in tumor migration and invasion through modulation of the c-Met signaling pathway.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/MIRN34 microRNA, human,
http://linkedlifedata.com/resource/pubmed/chemical/MicroRNAs,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 1,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-met
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1872-7980
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
8
|
pubmed:volume |
275
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
44-53
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:19006648-Adult,
pubmed-meshheading:19006648-Aged,
pubmed-meshheading:19006648-Carcinoma, Hepatocellular,
pubmed-meshheading:19006648-Cell Line, Tumor,
pubmed-meshheading:19006648-Cell Movement,
pubmed-meshheading:19006648-Down-Regulation,
pubmed-meshheading:19006648-Female,
pubmed-meshheading:19006648-Humans,
pubmed-meshheading:19006648-Liver Neoplasms,
pubmed-meshheading:19006648-Male,
pubmed-meshheading:19006648-MicroRNAs,
pubmed-meshheading:19006648-Middle Aged,
pubmed-meshheading:19006648-Mitogen-Activated Protein Kinase 1,
pubmed-meshheading:19006648-Mitogen-Activated Protein Kinase 3,
pubmed-meshheading:19006648-Neoplasm Invasiveness,
pubmed-meshheading:19006648-Neoplasm Metastasis,
pubmed-meshheading:19006648-Proto-Oncogene Proteins c-met
|
pubmed:year |
2009
|
pubmed:articleTitle |
miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
|
pubmed:affiliation |
Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing 100850, PR China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|